tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Income Statement

Compare
421 Followers

Trevi Therapeutics Income Statement

Last quarter (Q3 2024), Trevi Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Trevi Therapeutics's net income was $-13.24M. See Trevi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -123.00K$ -43.00K$ -50.00K$ -47.00K$ -39.00K
Operating Expenses
$ 33.92M$ 29.91M$ 32.48M$ 32.49M$ 26.64M
Depreciation and Amortization
$ 123.00K$ 43.00K$ 50.00K$ 47.00K$ 39.00K
EBITDA
$ -33.80M$ -29.86M$ -32.43M$ -32.44M$ -26.61M
Operating Income
$ -33.92M$ -29.91M$ -32.48M$ -32.49M$ -26.64M
Other Income/Expenses
$ 4.83M$ 719.00K$ -1.49M$ -287.00K$ 577.00K
Pretax Income
$ -29.10M$ -29.19M$ -33.96M$ -32.78M$ -26.07M
Net Income
$ -29.07M$ -29.15M$ -33.94M$ -32.76M$ -26.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.29$ -0.45$ -1.49$ -1.81$ -2.22
Diluted EPS
$ -0.29$ -0.45$ -1.49$ -1.81$ -2.22
Weighted Average Shares Outstanding
99.03M 64.54M 22.84M 18.06M 11.74M
Weighted Average Shares Outstanding (Diluted)
99.03M 64.54M 22.84M 18.06M 11.74M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis